GleamWall
中文EN

CNTB Connect Biopharma Holdings Ltd

Pharmaceutical Preparations · Nasdaq · SEC CIK 1835268 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY382.0%
TTM net income YoY-37.9%
TTM EPS YoY-28.1%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-1,879.9%
Net margin-1,849.7%
FCF margin-1,504.2%
EBITDA margin-1,861.7%

Returns

ROE-201.5%
ROA-142.8%
ROIC (approx.)-834.2%
Asset turnover0.08x

Leverage & solvency

Liabilities / assets56.6%
Debt / equity0.00x
Current ratio1.49x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.81x
Accruals ratio-26.7%
Payout ratio—
Capex / revenue0.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$64,000$26.03M
R&D expense$37.80M$29.26M
SG&A expense$20.34M$19.23M
Operating income-$58.07M-$22.45M
Pretax income-$55.28M-$15.40M
Income tax$197,000$223,000
Net income-$55.48M-$15.63M
EBITDA-$57.37M-$21.79M
EPS (basic)-1.00-0.28
EPS (diluted)-1.00-0.28
Weighted avg. shares (diluted)55.66M55.21M
Balance sheet
Cash & equivalents$38.34M$78.23M
Short-term investments$6.00M$15.48M
Receivables$13,000$789,000
Current assets$50.93M$96.96M
PP&E, net$3.81M$4.05M
Intangibles$45,000$53,000
Total assets$56.08M$101.28M
Current liabilities$13.61M$8.46M
Total liabilities$14.10M$9.12M
Shareholders' equity$41.98M$92.17M
Shares outstanding56.44M55.35M
Cash flow statement
Operating cash flow-$51.21M-$23.61M
Capital expenditure$434,000$750,000
Free cash flow-$51.64M-$24.36M
Investing cash flow$9.82M-$3.45M
Financing cash flow$1.09M$227,000
Depreciation & amortization$704,000$660,000
Stock-based compensation$3.73M$6.73M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.